{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-134026","form_type":"8-K","ticker":"MASS","cik":"0001555279","company_name":"908 Devices Inc.","filed_at":"2021-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.015457+00:00","generated_at":"2026-06-28T12:57:27.794935+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"908 Devices Q3 revenue $12.5M (+107% YoY), net loss $5.2M; narrows FY guidance to $41-43M","bullets":["Q3 revenue $12.5M, up 52% sequentially and 107% YoY; net loss $5.2M ($0.19 loss per share).","Product/service gross margin 54% vs 64% a year ago; operating expenses rose to $12.1M from $5.1M.","Installed base reached 1,714 devices with 184 placements in Q3, driven by handheld adoption.","Full year 2021 revenue guidance raised low end to $41-43M from $40-43M, growth 52-60%.","Cash $139M; $15M debt; launched ZipChip Oligonucleotides kit, partnered with Ohio AG for counterfeit drug detection."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-134026","json":"https://secwatch.observer/filing/0001104659-21-134026.json","markdown":"https://secwatch.observer/filing/0001104659-21-134026.md","text":"https://secwatch.observer/filing/0001104659-21-134026.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1555279/000110465921134026/0001104659-21-134026-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1555279/000110465921134026/tm2131861d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T12:57:27.794935+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}